20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Inspire Medical Systems Inc (INSP) operates in the MEDICAL DEVICES industry and is headquartered in Golden Valley, United States with about 1,333 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, INSP reported $912M in revenue and $145M in net income.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
Interactive charts & full statements → Open the INSP valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $899M | $912M | $803M | $625M | $408M | $233M | $115M | $82M | $51M | $29M | $16M | $8M |
| Gross Profit | $774M | $779M | $680M | $528M | $342M | $200M | $98M | $68M | $41M | $23M | $13M | $5M |
| Gross Margin % | 86.1% | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% | 84.7% | 83.4% | 80.1% | 78.9% | 76.2% | 64.9% |
| Operating Income (EBIT) | $54M | $51M | $36M | ($40M) | ($48M) | ($40M) | ($56M) | ($35M) | ($20M) | ($16M) | ($17M) | ($20M) |
| Operating Margin % | 6.0% | 5.6% | 4.5% | -6.5% | -11.7% | -17.1% | -48.7% | -42.5% | -40.3% | -56.0% | -105.0% | -247.1% |
| Net Income | $135M | $145M | $54M | ($21M) | ($45M) | ($42M) | ($57M) | ($33M) | ($22M) | ($18M) | ($19M) | ($21M) |
| Net Margin % | 15.0% | 16.0% | 6.7% | -3.4% | -11.0% | -18.0% | -49.6% | -40.5% | -43.1% | -61.3% | -112.8% | -266.3% |
| EBITDA | $83M | $80M | $65M | ($40M) | ($41M) | ($39M) | ($54M) | ($31M) | ($18M) | ($15M) | ($17M) | ($20M) |
| Earnings Per Share (EPS) | $4.61 | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | $-1.50 | $-1.30 | $-1.49 | $-1.71 |
| Shares Outstanding (M) | 29M | 30M | 31M | 29M | 28M | 27M | 26M | 24M | 15M | 13M | 12M | 12M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $201M | $205M | $269M | $225M | $217M | $201M | $240M | $203M |
| Gross Profit | $171M | $177M | $233M | $193M | $182M | $171M | $204M | $171M |
| Gross Margin % | 85.5% | 86.5% | 86.6% | 85.9% | 84.0% | 84.8% | 85.0% | 84.1% |
| Operating Income (EBIT) | ($1M) | ($1M) | $46M | $10M | ($3M) | ($1M) | $32M | $14M |
| Operating Margin % | -0.3% | -0.5% | 17.1% | 4.3% | -1.5% | -0.7% | 13.3% | 7.0% |
| Net Income | $0M | ($11M) | $136M | $10M | ($4M) | $3M | $35M | $18M |
| Net Margin % | 0.2% | -5.5% | 50.6% | 4.4% | -1.7% | 1.5% | 14.7% | 9.1% |
| EBITDA | $4M | $8M | $54M | $17M | $1M | $7M | $57M | $22M |
| Earnings Per Share (EPS) | $0.01 | $-0.39 | $4.66 | $0.34 | $-0.12 | $0.10 | $1.15 | $0.60 |
| Shares Outstanding (M) | 29M | 29M | 29M | 30M | 30M | 30M | 31M | 31M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $157M | $117M | $130M | $25M | $12M | ($20M) | ($53M) | ($33M) | ($19M) | ($16M) | ($18M) | ($22M) |
| Capital Expenditures (CapEx) | $40M | $38M | $39M | $24M | $9M | $5M | $2M | $3M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | $117M | $78M | $91M | $1M | $2M | ($25M) | ($56M) | ($36M) | ($19M) | ($16M) | ($18M) | ($23M) |
| FCF Margin % | 13.0% | 8.6% | 11.3% | 0.2% | 0.6% | -10.6% | -48.1% | -44.0% | -37.4% | -56.7% | -111.1% | -282.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $23M | $13M | $52M | $69M | $3M | ($7M) | $69M | $52M |
| Capital Expenditures (CapEx) | $9M | $10M | $11M | $10M | $9M | $8M | $7M | $8M |
| Free Cash Flow (FCF) | $14M | $3M | $42M | $58M | ($6M) | ($15M) | $62M | $44M |
| FCF Margin % | 7.0% | 1.5% | 15.5% | 25.9% | -2.9% | -7.5% | 25.9% | 21.8% |
| Dividends Paid | — | — | — | — | — | — | — | $6M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $926M | $907M | $808M | $677M | $565M | $295M | $281M | $181M | $200M | $25M | $13M |
| Cash & Cash Equivalents | $128M | $105M | $150M | $186M | $442M | $214M | $191M | $23M | $97M | $9M | $7M |
| Total Liabilities | $100M | $126M | $119M | $104M | $69M | $66M | $51M | $41M | $36M | $24M | $20M |
| Total Debt (Short + Long-Term) | $0M | $2M | $2M | $0M | $1M | $25M | $28M | $25M | $25M | $33M | $16M |
| Total Shareholders' Equity | $826M | $781M | $690M | $573M | $496M | $229M | $230M | $140M | $164M | $1M | ($7M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INSP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms